John Condemi
Allergy & Immunology · Rochester, NYNPI 1881662039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $906 and has fallen 91.6% since, to $76 in 2021. That places this record below the midpoint for allergy & immunology clinicians in NY, where the typical reported total is $2,174.
Across 47 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$264
- GSK$203
- Phadia US Inc.$75
- AstraZeneca$49
- Johnson & Johnson$47
- AbbVie$46
- plus $425 from 16 others
Across 11 payments — averaging $14,725 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$148K
- Merck$11K
- Novartis$2K
- Eli Lilly$17
What the payments were for
- Food & beverage$1,00991%
- Education$999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 5 | $264 |
| GSK | 7 | $203 |
| Phadia US Inc. | 1 | $75 |
| AstraZeneca | 3 | $49 |
| Johnson & Johnson | 3 | $47 |
| AbbVie | 3 | $46 |
| Amgen | 2 | $41 |
| Biocryst US Sales Co., LLC | 2 | $39 |
| Novartis | 2 | $39 |
| Grifols USA, LLC | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Optinose US, Inc. | 2 | $29 |
| Lilly USA, LLC | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Pfizer | 2 | $24 |
| UCB, Inc. | 1 | $23 |
| Alk-abello, Inc | 1 | $22 |
| Sanofi | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Pharming Healthcare, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$118
How this compares
$1,108 in reported general payments places this provider in the 40th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in Rochester
- Syed MustafaRochester$948K
- Carolina MarcusRochester$78K
- Theresa BingemannRochester$28K
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$946K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$643K
- Robert TamayevRego Park$321K
- Richard InselNew York$269K
- Payel GuptaBrooklyn$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.